Overview

Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )

Status:
Completed

Trial end date:
2016-11-01

Target enrollment:

Participant gender:

Summary

Biodistribution, pharmacokinetics, and safety of F-18 THK-5351 PET in Alzheimer's disease patients and healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Chang Gung Memorial Hospital